Mother of three urges cancer screening after indigestion led to incurable diagnosis

Maeve Fanning, a 38-year-old mother of three from Birmingham, is calling for wider cancer screening for people with autoimmune disorders after what she first thought was indigestion turned out to be an incurable cancer.

Fanning said she began experiencing persistent indigestion in October and attributed it to common digestive problems. She delayed seeing her general practitioner until she returned from a family holiday in Wales, and was initially prescribed antacids and advised that it could take a month to see improvement. Her symptoms worsened, she developed a cough that she believed was part of a seasonal outbreak, and a few days before Christmas she became breathless.

Scans taken on Dec. 20 revealed a significant amount of fluid in her lungs. Subsequent testing led doctors to diagnose an advanced, incurable cancer and to give her a prognosis of around two years, Fanning said. She had been diagnosed with a rare autoimmune disease about a year earlier.

Fanning said she initially dismissed the chest and stomach symptoms because they overlapped with complaints commonly experienced by people with autoimmune conditions and by patients recovering from respiratory infections. She is urging clinicians and patients alike to consider cancer screening when new, persistent symptoms appear, particularly in people with underlying autoimmune disorders.

In accounts provided to news outlets, Fanning described the emotional and practical impact of the diagnosis on her and her family. The diagnosis of an incurable illness prompted her to seek earlier testing and to press for further investigation after initial treatments failed to resolve the symptoms, according to her statements.

Medical practitioners note that symptoms such as persistent indigestion, a prolonged cough, unexplained breathlessness and new fluid in the chest can have multiple causes and may warrant timely investigation when they do not respond to first-line treatments. Early presentation and appropriate diagnostic imaging can change management for some conditions, though outcomes depend on the type and stage of any underlying disease.

Fanning's call for targeted screening reflects a concern among some patients that overlapping symptoms from chronic autoimmune conditions can delay the detection of malignancies. Health services typically follow established guidelines that prioritize screening based on age, risk factors and presenting symptoms. Individual cases can prompt reviews of how guidelines are applied in practice, particularly for patients with complex medical histories.

Fanning and her supporters are asking clinicians to have a lower threshold for investigation in patients with autoimmune diseases who report new or worsening symptoms. She has spoken publicly about the need for increased awareness and for better pathways to diagnostic testing, saying earlier detection could help other families avoid late-stage diagnoses.

Local health authorities did not provide a formal response to Fanning's case at the time of publication. Her situation highlights the tensions clinicians face in balancing the need to avoid unnecessary testing with the importance of identifying serious disease early. Fanning continues to receive care and has encouraged others experiencing unexplained, persistent symptoms to seek prompt medical advice and, where appropriate, further investigation.